Chandra Bhagat Pharma Ltd Share Price Today - Chandra Bhagat Pharma Ltd Stock Price Live NSE/BSE

Chandra Bhagat Pharma Ltd

NSE: BSE: 542934

₹34.76

(-4.98%)

Wed, 11 Mar 2026, 04:24 pm

MTF 5xInvest in Chandra Bhagat Pharma Ltd with 5x Leverage Buy with MTF

Market Cap0

PE Ratio0

Dividend0

Distribution Services

Medical Distributors

24.5K

Chandra Bhagat Pharma Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

Market Cap
27.60
Net Profit
0.86
P/B
1.32
Sector P/E
40.40
P/E
45.90
EV/EBITDA
14.66
Debt/Equity (Industry)
0.23
Interest Cover (Industry)
10.03
ROCE (Industry)
12.82
RONW (Industry)
12.23
ROE
2.41
ROCE
5.98
Debt/Equity
0.63
EPS (TTM)
0.94
Dividend Yield
0
Book Value
39.72
Interest Cover
1.48

Analysis

all

Pros

Chandra Bhagat Pharma is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
Chandra Bhagat Pharma is profitable, therefore cash runway is not a concern.
Chandra Bhagat Pharma is profitable, therefore cash runway is not a concern.
Debt is covered by short term assets, assets are 2.6x debt.
Chandra Bhagat Pharma's cash and other short term assets cover its long term commitments.

Cons

Unable to evaluate Chandra Bhagat Pharma's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
Unable to evaluate Chandra Bhagat Pharma's dividend against the top 25% market benchmark as the company has not reported any payouts.
Debt is not well covered by operating cash flow (12.2%, less than 20% of total debt).
Interest payments on debt are not well covered by earnings (EBIT is 1.4x annual interest expense, ideally 3x coverage).
Chandra Bhagat Pharma's level of debt (217.5%) compared to net worth is high (greater than 40%).

Financials

No Result Found

Ratios

No Result Found

Shareholders	SEPT 2025	MAR 2025	SEPT 2024	MAR 2024	SEPT 2023
Promoters	72.19	71.20	69.29	68.77	68.69
FII	0.61	0.61	0.48	1.33	1.33
DII	0	0	0	0.89	0.89
Public	27.20	28.19	30.23	29.01	29.09
Government	0	0	0	0	0

Technical Analysis

RSI

33.13

MACD

-1.91

50 DMA

44.16

200 DMA

63.36

Support and Resistance

Type	R3	R2	R1	PP	S1	S2	S3
Classic	51.28	45.28	42.37	39.28	36.37	33.28	27.28
Fibonacci	45.28	42.99	41.58	39.28	36.99	35.58	33.28
Camarilla	41.10	40.55	40	39.28	38.90	38.35	37.80

Pivots Level: Classic

+12

51.28

45.28

+3.08

42.37

39.28

Pivot Point

LTP: 34.76

-2.92

36.37

-6

33.28

-12

27.28

Moving Average

SMAEMA

Period

Value

10-EMA
38.39
20-EMA
39.81
30-EMA
41.19
50-EMA
44.13
100-EMA
51.24
200-EMA
63.66

Announcement Date	Purpose	Action
13 Nov 2025	board-meetings	Half Yearly Results
16 Sept 2025	agm
10 Sept 2024	agm
05 Sept 2023	agm
07 Sept 2022	agm
21 Oct 2021	agm

Peer Comparison

No Result Found

Chandra Bhagat Pharma Ltd

Dr Reddys Laboratories Ltd

Torrent Pharmaceuticals Ltd

Sun Pharmaceutical Industries Ltd

Divis Laboratories Ltd

Cipla Ltd

Chandra Bhagat Pharma Ltd About

Chandra Bhagat Pharma is primarily engaged in the Pharmaceutical Manufacturing,

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln

Founded

2003

Headquarters

CEO

Hemant C Bhagat

Employees

Contact

Website

http://www.cbcpharma.com

compliance@cbcpharma.net

Phone

91-22-24146154

Location

323-F Bhagat Bhuvan, Dr Ambedkar Road Matunga (E), Mumbai, Maharashtra, 400019

Year	History
2003	The company was incorporated as Chandra Bhagat Pharma Private Limited.
2015	The company entered into a supply and distribution agreement with Sinopharm India Private Limited for importing the HEPATITIS A vaccine.
2017	The company registered for the supply of APIs like Urokinase, L-Asparaginase, Heparin Sodium, and Enoxaparin Sodium.
2019	The Company was converted into a Public Limited Company. A fresh Certificate of Incorporation was issued by the Registrar of Companies, RoC – Mumbai.

Client Name	Order Side	QTY	Avg Price	Date
PRACHI PRANAV BHAGAT	Buy	62000	39.89	27 Feb 2026
PRACHI PRANAV BHAGAT	Buy	39000	53.84	28 Jul 2025
M7 GLOBAL FUND PCC - NOLANA	Buy	46000	64.61	19 Feb 2025
PIYUSH SECURITIES PVT LTD	Sell	63000	68.84	28 Nov 2024
PRACHI PRANAV BHAGAT	Buy	64000	68.84	28 Nov 2024
KAPIL AGARWAL HUF .	Sell	50000	65	27 Nov 2024
PIYUSH SECURITIES PVT LTD	Buy	63000	64.92	27 Nov 2024
SUNFLOWER BROKING PRIVATE LIMITED	Sell	48000	72.3	05 Nov 2024
ALACRITY SECURITIES LIMITED	Sell	51000	72.01	05 Nov 2024
SUNFLOWER BROKING PRIVATE LIMITED	Buy	48000	72	05 Nov 2024

Chandra Bhagat Pharma Ltd News

Chandra Bhagat Pharma Files Corporate Governance Exemption

Chandra Bhagat Pharma Limited filed certificate for non-applicability of corporate governance provisions for Q3 FY26 under SEBI Regulation 15, citing SME Exchange listing exemption.

21 Jan 2026

stocks

Chandra Bhagat Pharma Reports Half-Year Financial Results with Mixed Performance

Chandra Bhagat Pharma Limited announced unaudited financial results for the half-year ended September 30, 2025, showing revenue from operations of ₹2,354.60 lakhs and profit after tax of ₹44.91 lakhs. The company's board approved the results and announced that the trading window for insiders will open 48 hours after the financial statement announcement.

13 Nov 2025

earnings

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800